Pembrolizumab vs Trimethoprim
Pembrolizumab vs Trimethoprim: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Trimethoprim.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Trimethoprim — 8-10 hours.
Chemical Properties
Molecular Formula: Trimethoprim — C14H18N4O3.
Molecular Weight: Trimethoprim — 290.3180 g/mol.
Type: Pembrolizumab — Antibody; Trimethoprim — Small molecule.